Therakos

West Chester, United States Founded: 1984 • Age: 42 yrs Acquired By CVC
Therakos is focused on photopheresis systems for CTCL treatment.
Request Access

About Therakos

Therakos is a company based in West Chester (United States) founded in 1984 was acquired by CVC in August 2024. It operates as a HealthTech, and Direct-to-Consumer (D2C). Therakos offers products and services including THERAKOS CELLEX Photopheresis System and UVADEX (methoxsalen) Sterile Solution. Therakos operates in a competitive market with competitors including SetPoint Medical, Aura Biosciences, Philogen, OnQuality and Boomerang Medical, among others.

  • Headquarter West Chester, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Therakos Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    CVC

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    CVC

    & 2 more

    (Aug 05, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Therakos

Therakos offers a comprehensive portfolio of products and services, including THERAKOS CELLEX Photopheresis System and UVADEX (methoxsalen) Sterile Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Used for palliative treatment of CTCL skin manifestations.

Administered extracorporeally for CTCL skin symptom treatment.

Funding Insights of Therakos

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Therakos

Therakos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include CVC, Mallinckrodt Pharmaceuticals and The Gores Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Mezzanine financing and equity investments are provided by CVC.
Founded Year Domain Location
Private investments are made in mature businesses across multiple sectors.
Founded Year Domain Location
Specialty pharmaceutical products and diagnostic imaging agents are manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Therakos

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Therakos

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Therakos Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Therakos

Therakos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Aura Biosciences, Philogen, OnQuality and Boomerang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable neuromodulation devices are developed for inflammatory diseases.
domain founded_year HQ Location
Therapies are developed to target and destroy cancer cells selectively.
domain founded_year HQ Location
Antibody-based drugs are developed for angiogenesis-related cancers and disorders.
domain founded_year HQ Location
Therapeutics for skin cancers and related reactions are developed.
domain founded_year HQ Location
Bioelectronic devices are developed for autoimmune disease treatment.
domain founded_year HQ Location
Developer of a medical device to provide an automated test that detects allergies
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Therakos

Frequently Asked Questions about Therakos

When was Therakos founded?

Therakos was founded in 1984.

Where is Therakos located?

Therakos is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.

What does Therakos do?

Therakos is engaged in providing photopheresis solutions for the palliative treatment of cutaneous T-cell lymphoma (CTCL) skin manifestations. The company offers the THERAKOS CELLEX Photopheresis System and UVADEX (methoxsalen) Sterile Solution, targeting healthcare professionals in the United States. Services are extended through customer support, professional resources, and the Therakos Institute to build a community of expert operators. The focus is placed on the healthcare sector, specifically in dermatological and oncological treatment solutions.

Who are the top competitors of Therakos?

Therakos's top competitors include Philogen, SetPoint Medical and Aura Biosciences.

What products or services does Therakos offer?

Therakos offers THERAKOS CELLEX Photopheresis System and UVADEX (methoxsalen) Sterile Solution.

Who are Therakos's investors?

Therakos has 3 investors. Key investors include CVC, Mallinckrodt Pharmaceuticals, and The Gores Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available